title: [New aspects in the therapy of thrombosis and prevention of recurrence in pregnancy].
abstract: Therapy of phlebothrombosis during pregnancy general is carried out with heparin, in which case the initial hospital treatment may be continued later on with subcutaneous applications of heparin in the out-patient department. Regular clinical and apparative controls are performed during pregnancy within. Low dose heparin is injected up to the optimal dicumarol blood level (beginning with the 2nd day post partum) immediately pre-, intra- and postpartelly. - Coagulation analyses in 11 patients with former phlebothrombosis during pregnancy revealed no antithrombin III-deficiency, but hints to insufficient fibrinolysis in four cases.
mesh_terms: D001780:Blood Coagulation Tests; D004334:Drug Administration Schedule; D005260:Female; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D007279:Injections, Subcutaneous; D011186:Postphlebitic Syndrome / Q000188:drug therapy; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000188:drug therapy*; D012008:Recurrence; D013924:Thrombophlebitis / Q000188:drug therapy*
chemical_list: D006493:Heparin
vernacular_title: Neuere Aspekte der Thrombosetherapie und -rezidivprophylaxe während der Schwangerschaft.